United States · FDA National Drug Code directory
HAVRIX
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-3781_e0a78abf-4f24-4c13-ac00-6c193441275d
- Product NDC
- 50090-3781
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Hepatitis A Vaccine
- Labeler
- A-S Medication Solutions
- Marketing category
- BLA
- Marketing start / end (source format)
- 20070216
- Source listing expiry
- 20261231
Source-listed ingredients
- HEPATITIS A VIRUS STRAIN HM175 ANTIGEN (FORMALDEHYDE INACTIVATED) — 720 [iU]/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE in 1 CARTON (50090-3781-0) / .5 mL in 1 SYRINGE (50090-3781-1) · 50090-3781-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →